These souped-up versions may help overcome some limitations of existing CAR T cells. — ScienceDaily

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain types of blood cancers. Now, scientists at Memorial Sloan Kettering…

Click here to view the original article.